EN
HI
Summary
As of 26 Aug, 2026, Orchid Pharma stock price is ₹1038.55. During the trading session, the stock has moved between an intraday low of ₹1002.70 and an intraday high of ₹1043.95. Over the last 52 weeks, Orchid Pharma has traded between ₹480.00 and ₹1133.00.
The stock has recorded a trading volume of 59,978 shares, with a market capitalization of ₹50719105. Its Average Traded Price (ATP) is ₹1024.33, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 23 @ ₹1038.55.
Orchid Pharma has an upper circuit limit of ₹1245.70 and a lower circuit limit of ₹830.50. The total value traded stands at ₹6.14 CR, and the delivery percentage for the day is 57.13%.
The stock is currently traded with a market lot size of 1. Orchid Pharma also offers a dividend yield of 0%.
Orchid Pharma share price chart
Orchid Pharma Share Key Metrics
Volume
59978.00
Market Cap
5267.43 CR
LTQ@LTP
23@1038.55
ATP
1024.33
Var Margin
100 %
Circuit Range
830.5-1245.7
Delivery %
57.13 %
Value
6.14 CR
ASM/GSM
No
Market Lot
1
Orchid Pharma Fundamentals
P/E Ratio
717.43
P/B Ratio
4.78
Div. Yield
0
Sector P/E
69.22
Sector P/B
3.36
Sec. Div. Yield
0.51
Orchid Pharma Resistance and Support
Pivot 1027.37
Resistance
First Resistance
1059.74
Second Resistance
1081.37
Third Resistance
1113.74
Support
First Support
1005.74
Second Support
973.37
Third Support
951.74
Orchid Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Tue Aug 25 2026 | 1039.5 | 1038.55 | 0.04% | 1043.95 | 1002.7 |
| Mon Aug 24 2026 | 1020 | 1038.09 | 3.60% | 1049 | 995 |
| Fri Aug 21 2026 | 988.45 | 1002.04 | 2.24% | 1026 | 974.25 |
Orchid Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-14 | Quarterly Results |
| 2026-05-25 | Audited Results |
| 2026-02-11 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-26 | Audited Results |
| 2025-02-12 | Quarterly Results |
| 2024-11-11 | Quarterly Results |
| 2024-08-12 | Quarterly Results |
| 2026-08-01 | Allotment of Equity Shares |
Orchid Pharma News
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Orchid Pharma announced the upload of the audio recording for its Analysts/Investors Earnings Call, which took place on August 21, 2026. The call focused on the unaudited Q1 FY27 financial results, providing investors access to the detailed discussion.
Aug 21 2026 20:18:47
Orchid Pharma Ltd - 524372 - Statement Of Deviation Or Variation For The Quarter Ended June 30, 2026 On The Use Of Proceeds Of Funds Raised Through Qualified Institutional Placement
Orchid Pharma reported a deviation in the use of Qualified Institutional Placement (QIP) funds for Q1 FY27. The Alathur API facility project has been postponed, and the associated funds were reallocated to other approved purposes, including the Jammu manufacturing facility and debt repayment, with shareholder approval.
Aug 14 2026 20:11:32
Read More
Orchid Pharma Management
| Name | Position |
|---|---|
| Ram Gopal Agarwal | Chairman |
| Manish Dhanuka | Managing Director |
Orchid Pharma Similar Stocks
Senores Pharmaceuticals Ltd.
1480.40
-35.30 (2.33%)
Nephrocare Health Services Ltd.
697.35
10.10 (1.47%)
Kovai Medical Center & Hospital Ltd.
5985.50
60.00 (1.01%)
Innova Captab Ltd.
1040.40
-22.65 (2.13%)
Bliss GVS Pharma Ltd.
561.50
-3.40 (0.60%)
FDC Ltd.
343.65
-0.65 (0.19%)
Morepen Laboratories Ltd.
93.90
-1.32 (1.39%)
Supriya Lifescience Ltd.
791.65
-5.50 (0.69%)
Artemis Medicare Services Ltd.
323.70
-5.20 (1.58%)
IOL Chemicals And Pharmaceuticals Ltd.
172.37
3.29 (1.95%)
Orchid Pharma FAQs
The Buying Price of Orchid Pharma share is 1038.55 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Orchid Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Orchid Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Orchid Pharma shares is 717.43. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Orchid Pharma shares is 4.78. Useful to assess the stock's value relative to its book value.
To assess Orchid Pharma’s valuation compare Sector P/E, P/B which are 69.22 & 3.36 with sector averages, along with growth rates and financial metrics.
The Market Cap of Orchid Pharma is 5267.43 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Orchid Pharma share price is 1133.00 & 480.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Orchid Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in ORCHPHARMA
Or Download Choice FinX App
Invest in ORCHPHARMA
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade